Business Description

Bio-Rad Laboratories Incorporates develops and produces specialty chemicals for pharmaceutical and biochemical applications. The company was established in 1952 by David S. Schwartz and Alice N. Schwartz. It’s located in Hercules, CA. The Clinical Diagnostics segment designs manufacture, and markets test systems, test kits, and informatics. The Life Science segment designs and manufactures laboratory apparatus, reagents, and apparatus.

Key Financials

Revenue (US$ Mn):

• Bio-Rad Laboratories’ annual revenue for 2021 was US$ 2,923 Mn, a 14.81% increase from 2020
• The annual revenue generated by Bio-Rad Laboratories in 2020 was US$ 2,546 Mn
• At a 1% increase, Bio-Rad Laboratories’ annual revenue of US$ 2,312 Mn was indexed in 2019
• Bio-Rad Laboratories generated total revenue of US$ 2,289 Mn in 2018

Operating Income (US$ Mn):

• US$ 489 Mn was Bio-Rad Laboratories’ operating income in 2021, a 18.98% increase from 2020 figures
• Bio-Rad Laboratories indexed a 78.7% increase in operating incomes from 2019, amounting to US$ 411 Mn in 2020
• Bio-Rad Laboratories generated a operating income of US$ 230 Mn in 2019
• An operating income of US$ 189 Mn was indexed by Bio-Rad Laboratories in 2018

Net Income (US$ Mn):

• US$ 4,246 Mn was the net income generated by Bio-Rad Laboratories in 2021
• Bio-Rad Laboratories’ net income for 2020 was US$ 3,806 Mn, a 116.37% increase from 2019
• From 2018’s net incomes, Bio-Rad Laboratories registered a 380.6% increase in 2019, amounting to US$ 1,759 Mn
• A net income of US$ 366 Mn was generated in 2018 by Bio-Rad Laboratories

Operating Margin %:

• Bio-Rad Laboratories’ operating margin for 2021 was 17%, a 3.73% increase from 2020
• The operating margin generated by Bio-Rad Laboratories in 2020 was 16%
• At a 19.28% increase, Bio-Rad Laboratories’ operating margin of 10% was indexed in 2019
• Bio-Rad Laboratories generated an operating margin of 8% in 2018

Gross Margin %:

• 56% was Bio-Rad Laboratories’ gross margin in 2021, a -0.71% decrease from 2020 figures
• Bio-Rad Laboratories indexed a 3.86% increase in gross margins from 2019, amounting to 57% in 2020
• Bio-Rad Laboratories generated a gross margin of 54% in 2019
• A gross margin of 53% was indexed by Bio-Rad Laboratories in 2018

SWOT Analysis

Strength

A wide customer base and global presence protect the company from demand fluctuations

Bio-Rad serves a diverse customer base in different geographic markets. Bio-Rad’s global customer base includes top universities and research institutes. Customers include hospitals, public health, commercial and diagnostic laboratories, diagnostic manufacturers, and companies in the biotechnology and pharmaceutical, chemical, and food industries.

The company’s revenue comes from diverse geographic markets. The US segment was responsible for 39.5%, Europe (33.7%), Asia (21.5%), and Other (5.4%). 4%. The company also has operations in Canada, Latin America, and other regions. Bio-Rad has a large customer base and a significant presence in many geographic markets, which helps it to avoid fluctuations in demand in certain segments, markets, and regions.

Get this premium content

The Premium data is Locked

Buy Now to Unlock Premium Data

Request Sample Data